Related Tags >> vaccine AIDS vaccine Merck Anthony Fauci

HIV/AIDS News

Most Popular HIV/AIDS Story

HIV vax debacle linked to T-cell activation

November 6, 2008 — 9:27am ET | By John Carroll

The failure of Merck's HIV vaccine caused havoc in the field as the NIH pulled back and tried to find out what went wrong. Now French researchers led by Eric Kremer of the University of Montpellier... Read more...

HIV/AIDS Press Releases

T cell-based HIV vaccine candidate demonstrates positive results
New hope for HIV treatment: Cells exhausted from fighting HIV infection can be revitalized
New York City Mayor Bloomberg, Honorees Celebrate First Laboratory Solely Devoted to the Development of an AIDS Vaccine
Pfizer's Novel HIV/AIDS Treatment Selzentry (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naïve HIV Patients
FDA Approves Tibotec Therapeutics's PREZISTA Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1

Latest Headlines

T-cell HIV vax still promising
November 12, 2008
HIV vax debacle linked to T-cell activation
November 6, 2008
Nobel winners frustrated, hopeful about AIDS vax
October 9, 2008
VGX Pharma gets $23M NIH grant for HIV vax
October 6, 2008
Scripps wins $30M for HIV research center
October 2, 2008
Woman's immune system may be key to HIV vax
August 14, 2008
IAVI maps out a new route to AIDS vaccine
August 7, 2008
Fauci says HIV vaccine requires a new approach
July 31, 2008
Human protective system disables HIV vaccines
December 20, 2007

Paid Research Reports